[Answered] If a patient is going to be tube fed for longer than ____, a gastrostomy or jejunostomy may be ...

This topic contains a solution. Click here to go to the answer

Author Question: If a patient is going to be tube fed for longer than ____, a gastrostomy or jejunostomy may be ... (Read 69 times)

fasfsadfdsfa

Hero Member
Posts: 554

on: Aug 21, 2018

If a patient is going to be tube fed for longer than ____, a gastrostomy or jejunostomy may be necessary.
A) 1 week
B) 4 weeks
C) 2 months
D) 6 months

Question 2

What is the predominant sweetener used in formulating beverages?
A) glucose
B) sucrose
C) invert sugar
D) high-fructose corn syrup

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

ladyjames123

Sr. Member
Posts: 346

Reply #1 on: Aug 21, 2018

Answer to Question 1

B

Answer to Question 2

D

fasfsadfdsfa

Member
Posts: 554

Reply 2 on: Aug 21, 2018

YES! Correct, THANKS for helping me on my review

scikid

Member
Posts: 300

Reply 3 on: Yesterday

Wow, this really help

« previous next »

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.